Seagen Inc. - stock earnings
Stock symbol SGEN is outdated, potentially delisted? Maybe it is available on other exchange?
SGEN Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q1 | -174.7 million USD | 519.7 million USD |
| 2022Q4 | -148.2 million USD | 528.2 million USD |
| 2022Q3 | -190.8 million USD | 510.3 million USD |
| 2022Q2 | -134.8 million USD | 497.5 million USD |
| 2022Q1 | -136.5 million USD | 426.5 million USD |
| 2021Q4 | -174.6 million USD | 429.9 million USD |
| 2021Q3 | -293.8 million USD | 424.1 million USD |
| 2021Q2 | -84.6 million USD | 388.5 million USD |
| 2021Q1 | -121.4 million USD | 332.0 million USD |
| 2020Q4 | 167.1 million USD | 601.3 million USD |
| 2020Q3 | 636.2 million USD | 1.1 billion USD |
| 2020Q2 | -21.2 million USD | 278.0 million USD |
| 2020Q1 | -168.4 million USD | 234.5 million USD |
| 2019Q4 | 25.8 million USD | 289.8 million USD |
| 2019Q3 | -91.9 million USD | 213.3 million USD |
| 2019Q2 | -79.2 million USD | 218.4 million USD |
| 2019Q1 | -13.3 million USD | 195.2 million USD |
| 2018Q4 | -119.8 million USD | 174.5 million USD |
| 2018Q3 | -67.4 million USD | 169.4 million USD |
| 2018Q2 | 76.3 million USD | 170.2 million USD |
| 2018Q1 | -111.7 million USD | 140.6 million USD |
| 2017Q4 | -59.2 million USD | 129.6 million USD |
| 2017Q3 | 50.0 million USD | 135.3 million USD |
| 2017Q2 | -56.4 million USD | 108.2 million USD |
| 2017Q1 | -60.0 million USD | 109.1 million USD |
| 2016Q4 | -55.1 million USD | 105.3 million USD |
| 2016Q3 | -31.8 million USD | 106.3 million USD |
| 2016Q2 | -32.7 million USD | 95.4 million USD |
| 2016Q1 | -20.5 million USD | 111.2 million USD |
| 2015Q4 | -24.9 million USD | 93.5 million USD |
| 2015Q3 | -26.4 million USD | 84.1 million USD |
| 2015Q2 | -47.5 million USD | 77.1 million USD |
| 2015Q1 | -21.7 million USD | 82.2 million USD |
| 2014Q4 | -26.7 million USD | 74.3 million USD |
| 2014Q3 | -15.6 million USD | 75.9 million USD |
| 2014Q2 | -17.6 million USD | 68.3 million USD |
| 2014Q1 | -16.3 million USD | 68.3 million USD |
| 2013Q4 | -15.7 million USD | 67.4 million USD |
| 2013Q3 | -23.7 million USD | 71.0 million USD |
| 2013Q2 | -6.9 million USD | 73.6 million USD |
| 2013Q1 | -16.3 million USD | 57.3 million USD |
| 2012Q4 | -10.6 million USD | 63.9 million USD |
| 2012Q3 | -13.7 million USD | 49.8 million USD |
| 2012Q2 | -17.2 million USD | 48.8 million USD |
| 2012Q1 | -12.3 million USD | 48.2 million USD |
| 2011Q4 | -27.2 million USD | 48.9 million USD |
| 2011Q3 | -40.7 million USD | 20.7 million USD |
| 2011Q2 | -51.5 million USD | 13.1 million USD |
| 2011Q1 | -32.7 million USD | 12.2 million USD |
| 2010Q4 | -34.5 million USD | 8.1 million USD |
| 2010Q3 | -34.9 million USD | 16.0 million USD |
| 2010Q2 | -8.3 million USD | 36.9 million USD |
| 2010Q1 | 11.5 million USD | 46.5 million USD |
| 2009Q4 | -12.1 million USD | 21.8 million USD |
| 2009Q3 | -19.8 million USD | 11.6 million USD |
| 2009Q2 | -22.5 million USD | 9.4 million USD |
| 2009Q1 | -27.3 million USD | 9.1 million USD |
| 2008Q4 | -30.6 million USD | 10.1 million USD |
| 2008Q3 | -21.8 million USD | 8.1 million USD |
| 2008Q2 | -16.0 million USD | 10.0 million USD |
| 2008Q1 | -17.1 million USD | 7.1 million USD |
| 2007Q4 | -14.9 million USD | 7.8 million USD |
| 2007Q3 | -14.6 million USD | 4.6 million USD |
| 2007Q2 | -10.6 million USD | 5.6 million USD |
| 2007Q1 | -8.8 million USD | 4.3 million USD |
| 2006Q4 | -10.0 million USD | 2.6 million USD |
| 2006Q3 | -8.6 million USD | 2.4 million USD |
| 2006Q2 | -8.6 million USD | 2.8 million USD |
| 2006Q1 | -8.7 million USD | 2.1 million USD |
| 2005Q4 | -7.3 million USD | 2.3 million USD |
| 2005Q3 | -6.2 million USD | 2.6 million USD |
| 2005Q2 | -8.4 million USD | 2.2 million USD |
| 2005Q1 | -7.6 million USD | 2.6 million USD |
| 2004Q4 | -10.6 million USD | 1.7 million USD |
| 2004Q3 | -9.4 million USD | 1.5 million USD |
| 2004Q2 | -8.8 million USD | 1.5 million USD |
| 2004Q1 | -6.7 million USD | 2.0 million USD |
| 2003Q4 | -5.4 million USD | 1.3 million USD |
| 2003Q3 | -5.2 million USD | 1.5 million USD |
| 2003Q2 | -5.5 million USD | 1.5 million USD |
| 2003Q1 | -6.0 million USD | 710443 USD |
| 2002Q4 | -5.8 million USD | 634285 USD |
| 2002Q3 | -5.1 million USD | 404706 USD |
| 2002Q2 | -6.3 million USD | 375405 USD |
| 2002Q1 | -6.0 million USD | 269272 USD |
| 2001Q4 | -5.1 million USD | 169233 USD |
| 2001Q3 | -6.2 million USD | 70331 USD |
| 2001Q2 | -5.1 million USD | 34584 USD |
| 2001Q1 | -4.2 million USD | 1 USD |
| 2000Q4 | ? USD | 16000 USD |
| 2000Q3 | ? USD | 27000 USD |
| 2000Q2 | ? USD | 36000 USD |
| 2000Q1 | ? USD | 20000 USD |
SGEN Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -610.3 million USD | 2.0 billion USD |
| 2021 | -674.5 million USD | 1.6 billion USD |
| 2020 | 613.7 million USD | 2.2 billion USD |
| 2019 | -158.7 million USD | 916.7 million USD |
| 2018 | -222.7 million USD | 654.7 million USD |
| 2017 | -125.5 million USD | 482.3 million USD |
| 2016 | -140.1 million USD | 418.1 million USD |
| 2015 | -120.5 million USD | 336.8 million USD |
| 2014 | -76.1 million USD | 286.8 million USD |
| 2013 | -62.5 million USD | 269.3 million USD |
| 2012 | -53.8 million USD | 210.8 million USD |
| 2011 | -152.0 million USD | 94.8 million USD |
| 2010 | -66.3 million USD | 107.5 million USD |
| 2009 | -81.7 million USD | 52.0 million USD |
| 2008 | -85.5 million USD | 35.2 million USD |
| 2007 | -48.9 million USD | 22.4 million USD |
| 2006 | -36.0 million USD | 10.0 million USD |
| 2005 | -29.4 million USD | 9.8 million USD |
| 2004 | -35.4 million USD | 6.7 million USD |
| 2003 | -22.1 million USD | 5.1 million USD |
| 2002 | -23.2 million USD | 1.7 million USD |
| 2001 | -20.7 million USD | 274148 USD |
| 2000 | -7.8 million USD | 98632 USD |
SGEN
Price: $228.74
52 week price:
Payout Ratio Range:
Earnings Per Share: -4.01 USD
P/E Ratio: -54.52
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 869700
Ebitda: -37.1 millionMarket Capitalization: 41.2 billion